Bioworld Financial Watch articles from February 2002

Bioworld Financial Watch archives from February 2002

BIO pushing for PDUFA passage as early as June.
February 4, 2002... Any day now. Almost. That is , any day now, the creakingly slow mode of the FDA -- an what seems to be its increased willingness to delay approvals -- might get fixed, or be on its way to getting fixed. A new leader for the agency...

Money raised by Biotech in 2002 vs. 2001.
February 4, 2002... Money Raised By Biotech In 2002 Vs. 2001 Jan. 1 - Jan. 31, Jan. 1 - Feb. 1, 2002: $599.553 M 2001: $679.33 M Public/Other (*) 334 175 Private Biotechs 196 ...

10 Biggest U.S. Gainers & Losers for the Week.
February 4, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Carrington 86.67 Pharma Prod Devlp 4.44 Repligen 34.78 Myriad Genetics 2.83 Columbia Labs 31.82 Gilead Sciences 2.15...

U.S. Public offering performance by Underwriter: Jan. 1 - Dec. 31, 2001 (*).
February 4, 2002... U.S. Public Offering Performance By Underwriter: Jan. 1 - Dec. 31, 2001 (*) UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS JAN. 1 - DEC. 31, 2001; FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS (*) Underwriter ...

Underwriters' performance on all public offerings Jan. 1 - Dec. 31, 2001: Full credit to all underwriters, ranked by after-market performance.
February 4, 2002... UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS JAN. 1 - DEC. 31, 2001: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY AFTER-MARKET PERFORMANCE (*) (#) Underwriter (Number Of Offerings As Lead/ After-Market Number Of Offerings...

Underwriters' performance on IPOS from Jan. 1, 2001, to Dec. 31, 2001: Full credit to lead underwriter, ranked by Gross Proceeds & After-Market Performance.
February 4, 2002... UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2001, TO DEC. 31, 2001: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY GROSS PROCEEDS (*) Underwriter Gross (Number Of IPOs As Proceeds Lead Underwriter)...

Underwriters' performance on IPOS from Jan. 1, 2001, to Dec. 31, 2001: Full credit to all underwriters, ranked by Gross Proceeds & After-Market Performance.
February 4, 2002... UNDERWRITERS' PERFORMANCE ON IPOS FROM JAN. 1, 2001, TO DEC. 31, 2001: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS (*) Underwriter Gross (Number Of IPOs As Lead/Number Proceeds Of IPOs As Lead Or...

Underwriters' performance on all public offerings from Jan. 1, 2001, to Dec. 31, 2001: Full credit to lead underwriter, ranked by Gross Proceeds & After-Market Performance.
February 4, 2002... UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS FROM JAN. 1, 2001, TO DEC. 31, 2001: FULL CREDIT TO LEAD UNDERWRITER, RANKED BY GROSS PROCEEDS (*) Underwriter Gross (Number Of Offerings As Proceeds...

BioWorld stock report for public biotechnology companies.
February 4, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 1/25 2/1 WK YTD 3D Pharma DDDP 7.28 7.6 ...

Cephalon, industry thrown 'off balance' by Enron Storm.
February 11, 2002... If there's one thing for sure in biotechnology, it's uncertainty. And volatility, occasionally tilting into chaos. And hysteria, practically at the drop of a hat. Last week's hat blew off the head of Cephalon Inc., swept by winds...

10 biggest U.S. gainers for the week.
February 11, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Synsorb Biotech 41.05 Immtech 39.15 VaxGen 18.73 Sheffield 14.52 Oxis Int'l 14.29 Columbia Labs 7.13 Aclara Biosci 6.97 Maxygen ...

10 biggest U.S. losers for the week.
February 11, 2002... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Ista Pharma 31.15 Carrington -29.29 Collateral Thera -26.74 ZymoGenetics 25.39 QI.T PhotoTher -24.02 Organogenesis 23.85 Discovery...

Public financing of biotechnology: January 2002.
February 11, 2002... Public Financing of Biotechnology: January 2002 I. COMMENCED TRADING IN JANUARY Company Date Date Shares/ Price Shares/ (Symbol) (#) Filed Comm. Units (M) Out (M) INITIAL OFFERINGS ...

Other financings of public biotechnology companies: January 2002.
February 11, 2002... Other Financings of Public Biotechnology Companies: January 2002 TOTAL: $396.07M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: January 2002.
February 11, 2002... Venture capital and corporate investments in biotechnology companies: January 2002 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $340.98M Company Location Date Amt. (M) Achillion New...

Money raised by biotech in 2002: January.
February 11, 2002... Money raised by biotech in 2002: January Type of financing 1($M) Total ($M) Public offerings 75.1 75.1 Private biotechs 341.0 341.0 Public/other 396.1 396.1 Milestones/equity 11.0 11.0 ...

Bioworld stock report for public biotechnology companies.
February 11, 2002... BioWorld stock report for public biotechnology companies Company Symbol Close Close %Change Vol 2/1 2/8 WK YTD (000) 3D Pharma DDDP 7.6 7.25 ...

London Stock Exchange.
February 11, 2002... London Stock Exchange Company Symbol 2/1 2/8 %WK %YTD Volume Antigoma ASM 35.5 34 -4.23 -4.23 32 Acambis ACM 353 350 -0.85 -0.14 1833 British Biotech BBG...

Toronto Stock Exchange.
February 11, 2002... Toronto Stock Exchange Company Symbol 2/1 2/8 %WK %YTD Volume Adherex AHX 0.43 0.465 8.14 10.71 280 Angiolech Pharma ANP 88.64 85.25 -3.82 -4.21 237 Anormed ...

Biologics Manufacturing logjam: Can the industry meet demands?
February 18, 2002... "Logjam" and "bottleneck" became popular words as the industry entered what became called the "post-genomic era" (and grew into yet another oft-used phrase). But everybody was talking about data, not drugs - and that, of course, became the...

10 biggest U.S. gainers & losers for the week.
February 18, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Pharsight 27.72 Transkaryotic 4.18 Discovery Partners 19.22 Genzyme 2.83 Demegen 18.75 Digene 2.51 United...

Clinical trial update: January 2002.
February 18, 2002... Clinical Trial Update: January 2002 CANCER Company (*) Product (Symbol) Abgenix Inc. ABX-EGF (ABGX) Alfacell Corp. Onconase (OTC BB:ACEL) AltaRex...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: January 2002.
February 18, 2002... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: January 2002 CANCER Company (*) Product Description (Symbol) Alizyme plc ATL-104 Acts by stimulating the...

FDA submissions, approvals and other actions: January 2002.
February 18, 2002... FDA Submissions, Approvals And Other Actions: January 2002 CANCER Company Product Description (Symbol) Atrix Eligard One-month treatment; Laboratories (formerly leuprolide acetate that is...

BioWorld stock report for public biotechnology companies.
February 18, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change 2/8 2/15 W/K YTD 3D Pharma DDDP 7.25 7.25 ...

To partner, to merge? CEOs probe issues at BIO Conference.
February 25, 2002... NEW YORK -- The nitty-gritty of strategy, partnering and navigating the FDA were among topics covered during the fourth annual BIO CEO & Investor Conference last week, where about 1,500 registrants crowded the meeting rooms of the...

10 Biggest U.S. Gainers & Losers for the week.
February 25, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Gliatech 22.64 Ista Pharma 22.36 Digene 22.30 Albany Molecular 17.62 Neurobio Tech 17.07 Triangle Pharma 15.00 Alliance 14.54...

Biotech -- Big Pharma Collaborations: New agreements Nov. 15, 2001 -- Feb. 19, 2002.
February 25, 2002... Biotech -- Big Pharma Collaborations: New Agreements Nov. 15, 2001 -- Feb. 19, 2002 (#) Biotech Co. (*) (Country/ Pharma Co. Symbol) (Country) 3-Dimensional GlaxoSmithKline...

Manufacturing, marketing and distribution agreements between Biotechnology and Pharmaceutical Companies: Nov. 15, 2001 -- Feb. 19, 2002.
February 25, 2002... Manufacturing, Marketing And Distribution Agreements Between Biotechnology And Pharmaceutical Companies: Nov. 15, 2001 -- Feb. 19, 2002 (#) Biotech Co. (*) (Country/ Pharma Co. Symbol) (Country) ...

Biotech -- Big Pharma Collaborations: Modified and terminated agreements Nov. 15, 2001 - Feb. 19, 2002.
February 25, 2002... Biotech -- Big Pharma Collaboration: Modified And Terminated Agreements Nov. 15, 2001 - Feb. 19, 2002 (#) I. MODIFIED AGREEMENTS Biotech Co. (*) (Country/ Pharma Co. Symbol) (Country) Albany ...

BioWorld stock report for public Biotechnology Companies.
February 25, 2002... BioWorld Stock Report For Public Biotechnology Companies Close Close %Change Company Symbol 2/15 2/22 WK YTD 3D Pharma DDDP 7.25 6.79 ...

London Stock Exchange.
February 25, 2002... LONDON STOCK EXCHANGE Company Symbol 2/15 2/22 %WK %YTD Volume Antisoma ASM 29.5 24.5 -16.95 -30.99 759 Acambis ACM 365 350 -4.11 -0.14 2328 British...

Toronto Stock Exchange.
February 25, 2002... TORONTO STOCK EXCHANGE Company Symbol 2/15 2/22 %WK %YTD Volume Adherex AHX 0.48 0.49 2.08 16.67 116 Angiotech Pharma ANP 85.3 85.34 0.05 -4.11 298 Anormed ...